In general, the development of disease models that accurately reflect relatively milder forms of SMA has not been straightforward, suggesting that in mice, the range of variation in SMN protein expression may be narrower than in humans (O'Hern et al., 2017), complicating the generation of models with intermediate phenotypes required for studying milder forms of SMA. Here, SMN2 is linked to proximal spinal muscular atrophy.